OKAVA
Biotechnology ResearchCalifornia, United States2-10 Employees
Clinical stage biotechnology company focused on developing drugs for the unique needs of dogs and cats.
Niche Market Focus OKAVA operates in the specialized field of veterinary biotechnology targeting drugs for dogs and cats, presenting opportunities to partner with biotech suppliers and veterinary product distributors focusing on pet healthcare innovations.
Emerging Financial Potential With a revenue estimate between 1 million and 10 million dollars, OKAVA is positioned as a growing company with potential for increased partnerships in medical research tools, laboratory services, and clinical trial support for animal health.
Tech-Enabled Operations Utilization of advanced web technologies indicates a modern, digitally savvy company open to collaborative platforms, cloud-based research tools, and data management solutions tailored for biotech startups.
Strategic Industry Position Although small in size, OKAVA is aligned within a competitive sector alongside industry giants, highlighting opportunities for niche service providers or strategic investors to support its clinical development phases.
Innovation-Driven Growth Focus on developing drugs for pet health reflects a growing market trend towards specialized, scientifically backed pet care products, suggesting opportunities in marketing, distribution, and research collaboration within the veterinary biotech space.
OKAVA uses 8 technology products and services including Webpack, Bunny Fonts, Yoast SEO, and more. Explore OKAVA's tech stack below.
| OKAVA Email Formats | Percentage |
| First.Last@okavapharma.com | 50% |
| First.Last@okavapharma.com | 50% |
Biotechnology ResearchCalifornia, United States2-10 Employees
Clinical stage biotechnology company focused on developing drugs for the unique needs of dogs and cats.
OKAVA's revenue is estimated to be in the range of $1M$10M
OKAVA's revenue is estimated to be in the range of $1M$10M